Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garnet Suck

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Bioscience (Elite Edition)|January 4, 2011
KHYG-1 and NK-92 represent different subtypes of LFA-1-mediated NK cell adhesivenessGarnet Suck, Suet-Mien Tan, Sixian Chu, et al.
International Immunology|January 18, 2006
B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinaseSonia Néron, Garnet Suck, Xue-Zhong Ma, et al.
Transfusion|March 9, 2005
Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cellsGregory C Rampersad, Garnet Suck, Darinka Sakac, et al.
Experimental Hematology|June 28, 2011
Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignanciesGarnet Suck, Vincent Y S Oei, Yeh Ching Linn, et al.
Experimental Hematology|June 28, 2011
Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapyMadelaine Niam, Yeh-Ching Linn, Stephanie Fook Chong, et al.
Biology|May 28, 2022
Autologous Blood Doping Induced Changes in Red Blood Cell Rheologic Parameters, RBC Age Distribution, and PerformanceMarijke Grau, Emily Zollmann, Janina Bros, et al.
Cytotherapy|July 18, 2012
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remissionYeh-Ching Linn, Hao-Xiang Yong, Madelaine Niam, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Bioscience (Elite Edition)|January 4, 2011
KHYG-1 and NK-92 represent different subtypes of LFA-1-mediated NK cell adhesivenessGarnet Suck, Suet-Mien Tan, Sixian Chu, et al.
International Immunology|January 18, 2006
B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinaseSonia Néron, Garnet Suck, Xue-Zhong Ma, et al.
Transfusion|March 9, 2005
Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cellsGregory C Rampersad, Garnet Suck, Darinka Sakac, et al.
Experimental Hematology|June 28, 2011
Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignanciesGarnet Suck, Vincent Y S Oei, Yeh Ching Linn, et al.
Experimental Hematology|June 28, 2011
Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapyMadelaine Niam, Yeh-Ching Linn, Stephanie Fook Chong, et al.
Biology|May 28, 2022
Autologous Blood Doping Induced Changes in Red Blood Cell Rheologic Parameters, RBC Age Distribution, and PerformanceMarijke Grau, Emily Zollmann, Janina Bros, et al.
Cytotherapy|July 18, 2012
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remissionYeh-Ching Linn, Hao-Xiang Yong, Madelaine Niam, et al.
Pageof 2